Wang J - Search Results

1

Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives.

Fu W, Wang J, Yu L, Zhao L, Lu N, You Q, Guo Q, Li Z. Fu W, et al. Among authors: wang j. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1118-21. doi: 10.1016/j.bmcl.2011.11.117. Epub 2011 Dec 6. Bioorg Med Chem Lett. 2012. PMID: 22196122

2

Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors.

Zhang X, Wang R, Zhao L, Lu N, Wang J, You Q, Li Z, Guo Q. Zhang X, et al. Among authors: wang j, wang r. Bioorg Med Chem Lett. 2012 Jan 15;22(2):1276-81. doi: 10.1016/j.bmcl.2011.10.019. Epub 2011 Oct 24. Bioorg Med Chem Lett. 2012. PMID: 22079759

3

Synthesis and biological evaluation of baicalein derivatives as potent antitumor agents.

Luo R, Wang J, Zhao L, Lu N, You Q, Guo Q, Li Z. Luo R, et al. Among authors: wang j. Bioorg Med Chem Lett. 2014 Mar 1;24(5):1334-8. doi: 10.1016/j.bmcl.2014.01.053. Epub 2014 Jan 27. Bioorg Med Chem Lett. 2014. PMID: 24507925

4

Synthesis, evaluation and quantitative structure-activity relationship (QSAR) analysis of Wogonin derivatives as cytotoxic agents.

Bian J, Li T, Weng T, Wang J, Chen Y, Li Z. Bian J, et al. Among authors: wang j. Bioorg Med Chem Lett. 2017 Feb 15;27(4):1012-1016. doi: 10.1016/j.bmcl.2016.12.076. Epub 2017 Jan 5. Bioorg Med Chem Lett. 2017. PMID: 28117202

5

Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro.

Wang J, Ge R, Qiu X, Xu X, Wei L, Li Z, Bian J. Wang J, et al. Eur J Med Chem. 2017 Nov 10;140:421-434. doi: 10.1016/j.ejmech.2017.09.046. Epub 2017 Sep 22. Eur J Med Chem. 2017. PMID: 28987604

6

Exploring the tetrahydroisoquinoline thiohydantoin scaffold blockade the androgen receptor as potent anti-prostate cancer agents.

Xu X, Ge R, Li L, Wang J, Lu X, Xue S, Chen X, Li Z, Bian J. Xu X, et al. Among authors: wang j. Eur J Med Chem. 2018 Jan 1;143:1325-1344. doi: 10.1016/j.ejmech.2017.10.031. Epub 2017 Oct 14. Eur J Med Chem. 2018. PMID: 29117897

7

Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy.

Weng T, Qiu X, Wang J, Li Z, Bian J. Weng T, et al. Among authors: wang j. Eur J Med Chem. 2018 Jan 1;143:656-669. doi: 10.1016/j.ejmech.2017.11.088. Epub 2017 Dec 1. Eur J Med Chem. 2018. PMID: 29220788 Review.

8

Current knowledge on the nucleotide agonists for the P2Y2 receptor.

Xu P, Feng X, Luan H, Wang J, Ge R, Li Z, Bian J. Xu P, et al. Among authors: wang j. Bioorg Med Chem. 2018 Jan 15;26(2):366-375. doi: 10.1016/j.bmc.2017.11.043. Epub 2017 Dec 2. Bioorg Med Chem. 2018. PMID: 29254895 Review.

9

Palladium(II)-Catalyzed Reaction of Lawsones and Propargyl Carbonates: Construction of 2,3-Furanonaphthoquinones and Evaluation as Potential Indoleamine 2,3-Dioxygenase Inhibitors.

Feng X, Qiu X, Huang H, Wang J, Xu X, Xu P, Ge R, Liu X, Li Z, Bian J. Feng X, et al. Among authors: wang j. J Org Chem. 2018 Aug 3;83(15):8003-8010. doi: 10.1021/acs.joc.8b00872. Epub 2018 Jun 15. J Org Chem. 2018. PMID: 29882670

10

Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions.

Xu X, Meng Y, Li L, Xu P, Wang J, Li Z, Bian J. Xu X, et al. Among authors: wang j. J Med Chem. 2019 Feb 14;62(3):1096-1115. doi: 10.1021/acs.jmedchem.8b00961. Epub 2018 Sep 7. J Med Chem. 2019. PMID: 30148361

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218,604 results

Search Page

Filters